Quote & Headlines
Market Currents
StockTalk
Today
5d
1m
3m
1y
5y
10y
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
207 people get RTIX articles and Market Currents by email alert.
Get email alerts on RTIX »
HEADLINES:
ALL
|
PRO
|
FOCUS
|
RELATED
|
TRANSCRIPTS
|
NEWS & PR
-
-
Business Wire (Apr 25, 2013)
-
Business Wire (Apr 18, 2013)
-
Business Wire (Mar 13, 2013)
-
-
Business Wire (Feb 7, 2013)
-
Business Wire (Jan 31, 2013)
-
-
-
Business Wire (Jan 7, 2013)
-
Business Wire (Oct 26, 2012)
-
Business Wire (Oct 25, 2012)
-
Business Wire (Oct 18, 2012)
-
Business Wire (Sep 27, 2012)
-
-
Business Wire (Jul 31, 2012)
To learn more about Seeking Alpha Pro, click here.
-
-
-
-
-
-
Update: 8 High-Growth Healthcare Stocks With Strong Sources Of ProfitabilityKapitall • Tue, Jul 17, 2012 -
-
12 Highly Liquid Healthcare Stocks With Strong Sales TrendsKapitall • Tue, Jul 3, 2012
-
4 Extremely Undervalued Stocks To Add To Your PortfolioLeonid Kanopka • Mon, Mar 19, 2012 -
8 Oversold Stocks With Strong Inventory TrendsKapitall • Thu, Feb 2, 2012
-
-
Activist Hedge Fund Accipiter Capital's Top Stock PicksInsider Monkey • Tue, Nov 29, 2011 -
Top Q3 Picks Of Biotech-Focused Hedge Fund DAFNA CapitalGuruFundPicks • Fri, Nov 18, 2011 -
-
-
-
-
-
4 Healthcare Stocks With Positive Correlation To Market VolatilityKapitall • Tue, Sep 20, 2011
-
20 Healthcare Stocks With Positive Accounts Receivable TrendsKapitall • Tue, Sep 13, 2011
-
RTI Biologics Inc. Q2 2010 Earnings Call TranscriptFri, Aug 6, 2010
-
RTI Biologics, Inc. Q1 2010 Earnings Call TranscriptWed, Apr 28, 2010
-
RTI Biologics, Inc. Q4 2009 Earnings Call TranscriptTue, Feb 9, 2010
-
RTI Biologics, Inc., Q3 2009 Earnings Call TranscriptWed, Oct 28, 2009
-
RTI Biologics Inc. Q1 2009 Earnings Call TranscriptThu, Apr 30, 2009
-
RTI Biologics Inc. Q4 2008 Earnings Call TranscriptFri, Feb 20, 2009
-
RTI Biologics, Inc. Q3 2008 Earnings Call TranscriptTue, Oct 28, 2008
-
RTI Biologics Inc. Q1 2008 Earnings Call TranscriptFri, May 23, 2008
-
Business Wire (Apr 25, 2013)
-
Business Wire (Apr 18, 2013)
-
Business Wire (Mar 13, 2013)
-
Business Wire (Feb 7, 2013)
-
Business Wire (Jan 31, 2013)
-
Business Wire (Jan 7, 2013)
-
Business Wire (Oct 26, 2012)
-
Business Wire (Oct 25, 2012)
-
Business Wire (Oct 18, 2012)
-
Business Wire (Sep 27, 2012)
-
Business Wire (Jul 31, 2012)
-
Business Wire (Jul 23, 2012)
-
Business Wire (Apr 26, 2012)
-
Business Wire (Apr 19, 2012)
-
Business Wire (Jan 24, 2012)
-
Business Wire (Jan 10, 2012)
-
Business Wire (Dec 28, 2011)
-
at MarketWatch.com (Jul 13, 2011)
RTIX vs. ETF Alternatives
Company Description
Currently, there's no company description for RTIX.
- All
- | Earnings
- | Dividends
- | M&A
- | On the move
- Thursday, April 25, 9:40 AM RTI Biologics (RTIX): Q1 EPS of $0.03 beats by $0.01. Revenue of $40.4M beats by $1.64M. (PR) Comment! [Earnings, Breaking News, Healthcare]
- Thursday, February 7, 2:32 PM RTI Biologics (RTIX -12.7%) gets smacked today after its Q4 EPS came in-line with forecasts, but revenue misses analyst estimates on weakness in its surgical specialties and sports medicine businesses. The company also issued downbeat guidance, saying sales and profit during the first half of the year will be weak due to customer reaction to its FDA warning letter over contaminated human tissue implants. Comment! [Healthcare, Earnings, On the Move]
-
Thursday, February 7, 1:05 PM
Midday top 10 gainers: SUTR +40%. FMFC +39%. OXGN +23%. VSAT +22%. TRLG +20%. GEOS +20%. DV +18%. ARKR +17%. PLNR +16%. SCKT +15%.
Midday top 10 losers: AKAM -16%. ADEP -16%. EPAX -15%. OSUR -14%. SGMO -14%. IRBT -13%. ATML -13%. BONT -13%. RTIX -13%. PSMI -12%. Comment! [On the Move] - Thursday, February 7, 8:13 AM RTI Biologics (RTIX): Q4 EPS of $0.04 in-line. Revenue of $44.6M (+4% Y/Y) misses by $0.54M. (PR) Comment! [Earnings, Breaking News, Healthcare]
- Thursday, October 25, 2012, 9:45 AM RTI Biologics (RTIX): Q3 EPS of $0.05 beats by $0.01. Revenue of $44.6M (+10.2% Y/Y) in-line. (PR) Comment! [Earnings, Healthcare]
- Tuesday, July 31, 2012, 9:12 AM RTI Biologics (RTIX): Q2 EPS of $0.05 beats by $0.01. Revenue of $45.2M (+4% Y/Y) beats by $0.96M. Shares +2.9% premarket. (PR) Comment! [Earnings, Healthcare, On the Move]
- Thursday, April 26, 2012, 11:43 AM Regeneration Technologies (RTIX): Q1 EPS of $0.04 beats by $0.01. Revenue of $43.7M (+7.6% Y/Y) beats by $1.8M. (PR) Comment! [Earnings, Healthcare]
- Tuesday, January 31, 2012, 4:05 PM RTI Biologics (RTIX -13.5%) trades down into the close despite beating Q4 estimates. Profit actually declined 5.5% Y/Y due to inventory issues, which masked a 20% jump in international sales. The company warns on FY12 guidance however, now saying it expects revenue in the range of $174M - $176M. Analysts are looking for sales of $176M. Comment! [On the Move, Healthcare]
- Tuesday, January 31, 2012, 8:08 AM Regeneration Technologies (RTIX): Q4 EPS of $0.04 beats by $0.01. Revenue of $42.9M (-5.5% Y/Y) beats by $1.5M. (PR) Comment! [Earnings, Healthcare]
Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.